Cargando…
Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-κB) pathway
This study aimed to explore the effects of plumbagin on rheumatoid arthritis (RA) and its mechanism. The RA cell model was simulated following the treatment of interleukin-1β (IL-1β). After the treatment of various concentrations of plumbagin, the impact of plumbagin on the cell viability was examin...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276045/ https://www.ncbi.nlm.nih.gov/pubmed/35653787 http://dx.doi.org/10.1080/21655979.2022.2081756 |
_version_ | 1784745630445338624 |
---|---|
author | Shu, Chang Chen, Jun Lv, Meiyan Xi, Yiyuan Zheng, Jujia Xu, Xiangwei |
author_facet | Shu, Chang Chen, Jun Lv, Meiyan Xi, Yiyuan Zheng, Jujia Xu, Xiangwei |
author_sort | Shu, Chang |
collection | PubMed |
description | This study aimed to explore the effects of plumbagin on rheumatoid arthritis (RA) and its mechanism. The RA cell model was simulated following the treatment of interleukin-1β (IL-1β). After the treatment of various concentrations of plumbagin, the impact of plumbagin on the cell viability was examined by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The collagen-induced arthritis (CIA) model was established using the solution of bovine type II collagen. Hematoxylin-eosin staining was used to observe the changes of ankle joint tissue, while enzyme-linked immunosorbent assay and western blot were applied to detect the level of inflammatory cytokines. Plumbagin inhibited the viability of human fibroblast-like synoviocytes (HFLS) at the concentration of 1 ~ 3.5 μM. The inhibitory effect of 1 μM plumbagin on cell proliferation was similar to that of methotrexate, the drug used as the positive control. Plumbagin downregulated the levels of inflammatory cytokines and matrix metalloproteinases (MMPs) in IL-1β-treated HFLS, and suppressed the activation of IκB and nuclear factor kappa-B (NF-κB) as well as the entry of p65 into the nucleus. It was also demonstrated in animal experiments that plumbagin inhibited the activation of NF-κB pathway, down-regulated the levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and MMPs, and alleviated joint damage in CIA-modeled mice. Collectively speaking, plumbagin might down-regulate the levels of inflammatory cytokines and MMPs through inhibiting the activation of the NF-κB pathway, thereby attenuating RA-induced damage to cells and joints. Abbreviations: CIA: Collagen-induced arthritis; ELISA: Enzyme-linked immuno sorbent assay; HFLS: Human fibroblast-like synoviocytes; IL-6: Interleukin-6; IL-1β: Interleukin-1β; NF-κB: nuclear factor kappa-B; MTT: 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; MMPs: Matrix metalloproteinase; OD: Optical density; RA: Rheumatoid arthritis; SDS: Sodium dodecyl sulfate; SD: Standard deviation; TNF-α: Tumor necrosis factor-α; PVDF: Polyvinylidene fluoride. |
format | Online Article Text |
id | pubmed-9276045 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-92760452022-07-13 Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-κB) pathway Shu, Chang Chen, Jun Lv, Meiyan Xi, Yiyuan Zheng, Jujia Xu, Xiangwei Bioengineered Research Paper This study aimed to explore the effects of plumbagin on rheumatoid arthritis (RA) and its mechanism. The RA cell model was simulated following the treatment of interleukin-1β (IL-1β). After the treatment of various concentrations of plumbagin, the impact of plumbagin on the cell viability was examined by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The collagen-induced arthritis (CIA) model was established using the solution of bovine type II collagen. Hematoxylin-eosin staining was used to observe the changes of ankle joint tissue, while enzyme-linked immunosorbent assay and western blot were applied to detect the level of inflammatory cytokines. Plumbagin inhibited the viability of human fibroblast-like synoviocytes (HFLS) at the concentration of 1 ~ 3.5 μM. The inhibitory effect of 1 μM plumbagin on cell proliferation was similar to that of methotrexate, the drug used as the positive control. Plumbagin downregulated the levels of inflammatory cytokines and matrix metalloproteinases (MMPs) in IL-1β-treated HFLS, and suppressed the activation of IκB and nuclear factor kappa-B (NF-κB) as well as the entry of p65 into the nucleus. It was also demonstrated in animal experiments that plumbagin inhibited the activation of NF-κB pathway, down-regulated the levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and MMPs, and alleviated joint damage in CIA-modeled mice. Collectively speaking, plumbagin might down-regulate the levels of inflammatory cytokines and MMPs through inhibiting the activation of the NF-κB pathway, thereby attenuating RA-induced damage to cells and joints. Abbreviations: CIA: Collagen-induced arthritis; ELISA: Enzyme-linked immuno sorbent assay; HFLS: Human fibroblast-like synoviocytes; IL-6: Interleukin-6; IL-1β: Interleukin-1β; NF-κB: nuclear factor kappa-B; MTT: 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; MMPs: Matrix metalloproteinase; OD: Optical density; RA: Rheumatoid arthritis; SDS: Sodium dodecyl sulfate; SD: Standard deviation; TNF-α: Tumor necrosis factor-α; PVDF: Polyvinylidene fluoride. Taylor & Francis 2022-06-02 /pmc/articles/PMC9276045/ /pubmed/35653787 http://dx.doi.org/10.1080/21655979.2022.2081756 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Shu, Chang Chen, Jun Lv, Meiyan Xi, Yiyuan Zheng, Jujia Xu, Xiangwei Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-κB) pathway |
title | Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-κB) pathway |
title_full | Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-κB) pathway |
title_fullStr | Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-κB) pathway |
title_full_unstemmed | Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-κB) pathway |
title_short | Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-κB) pathway |
title_sort | plumbagin relieves rheumatoid arthritis through nuclear factor kappa-b (nf-κb) pathway |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276045/ https://www.ncbi.nlm.nih.gov/pubmed/35653787 http://dx.doi.org/10.1080/21655979.2022.2081756 |
work_keys_str_mv | AT shuchang plumbaginrelievesrheumatoidarthritisthroughnuclearfactorkappabnfkbpathway AT chenjun plumbaginrelievesrheumatoidarthritisthroughnuclearfactorkappabnfkbpathway AT lvmeiyan plumbaginrelievesrheumatoidarthritisthroughnuclearfactorkappabnfkbpathway AT xiyiyuan plumbaginrelievesrheumatoidarthritisthroughnuclearfactorkappabnfkbpathway AT zhengjujia plumbaginrelievesrheumatoidarthritisthroughnuclearfactorkappabnfkbpathway AT xuxiangwei plumbaginrelievesrheumatoidarthritisthroughnuclearfactorkappabnfkbpathway |